Gujarat Kidney and Super Speciality Ltd

NSE: GKSL · BSE: 544666 · Healthcare · 30 announcements

Share price: ₹187.12
Market cap: ₹1,475 Cr
Revenue (annual): ₹82.01 Cr
Net profit (annual): ₹15.50 Cr
P/E (TTM): 93.2×Sector 53.1×
Promoter holding: 71.45%+0.00% QoQ
FII holding: 4.89%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Management Change 6 Annual General Meeting 6 Financial Results 4 Legal & Regulatory 3 Other Announcement 2 Merger & Restructuring 2 Board Meeting Outcome 2 Board Meeting Date 2 Annual Report 2 Capacity Expansion 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

28 May 2026 23:44 IST NSE

Board Meeting Outcome

Gujarat Kidney and Super Speciality Board Meeting Outcome

Gujarat Kidney and Super Speciality Limited appointed Siddharth Shah as Internal Auditor and SPANJ & Associates as Secretarial Auditor. These governance appointments ensure statutory compliance.

Execution: 60 months

Read the filing ↗

27 Apr 2026 22:00 IST NSE

Board Meeting Outcome

Gujarat Kidney and Super Speciality Board Meeting Outcome

Gujarat Kidney and Super Speciality Limited approved the appointment of Ms. Vishakha Mahesh Phadke as Company Secretary and Compliance Officer. The Board also approved incorporating a ₹0.01 Crore wholly-owned healthcare subsidiary in Bharuch, Gujarat. Additionally, the Board noted shareholder approval for interim IPO fund utilization, financial statement revisions, and secretarial auditor appointment.

Value: ₹0.01 Cr
Execution: On or before end of first half of the FY 2026-27

Read the filing ↗